home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

ADME Screening: When to Start?

 
  May 11, 2004  
     
 
Reed Business Information, Online
May 26, 2004


Please join DRUG DISCOVERY& DEVELOPMENT magazine and a panel of industry experts as we discuss early-stage ADME screening, the tools and technology available for pre-clinical pharmacokinetic testing of compounds, and their predictive value in drug development. It’s an ideal opportunity to:

- Learn about new ADME screening tools from case studies by pharmaceutical researchers who make daily “go”/“no go”
decisions about pursuing therapeutic programs.

- Interact with the panelists during the live webcast to ask technical and scientific questions about how best to incorporate available technologies in early stage ADME screening.

 
 
Organized by: Reed Business Informtion
Invited Speakers: - Tanuja Koppal, PhD, Senior Editor, DRUG DISCOVERY &
DEVELOPMENT
- JoAnn Scatina, PhD; Assistant Vice President,
Drug Safety and Metabolism, Wyeth Pharmaceuticals

- Navita L. Mallalieu, PhD, Senior Principal Scientist,
Discovery Pharmacology, Hoffmann-La Roche

- Bernard Faller, PhD, Head, Profiling Group, Basel
Discovery Technologies, Novartis

 
Deadline for Abstracts: passed
 
Registration: Registration is FREE! To register for this event, please visit http://www.reedbusinessinteractive.com/scripts/Register.asp?id=17
E-mail: maria.palombini@reedbusiness.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.